Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Novel multifunctional agent for neuroprotection

Sep. 30, 2005

Glycominds test may predict active MS

Sep. 30, 2005

Agonists of mGlu8 and mGlu2/3 receptors may be useful for mood and anxiety disorders

Sep. 30, 2005

DOV-216303 shows promise in the management of major depression

Sep. 29, 2005

ADX-10059 enters phase I studies for anxiety disorders and migraine

Sep. 29, 2005

Corcept closes enrollment in Corlux study in Alzheimer's patients

Sep. 29, 2005

Revised reporting date for phase III study of Corlux

Sep. 29, 2005

NAP and ADNF-9 exert neuroprotective effects via PARP-1 activation and polyADP-ribosylation

Sep. 29, 2005

Supplemental BLA submitted for Tysabri for MS

Sep. 28, 2005

Recent Sumitomo patent covers novel treatments for anxiety and depression

Sep. 28, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...